Cytogenetics and acute non lymphocytic leukemia.
The authors report haematologic and cytogenetic data from 47 patients with ANLL, demonstrating the usefulness of cytogenetic studies for the classification as well as for the prognosis of this disorder. Chromosome studies also permitted the classification of marrow cellularity in: all diploid metaphases (NN), diploid and aneuploid metaphases (AN), and all aneuploid metaphases (AA). The remission rate for patients in whom only normal metaphases were detected (NN patients) was 83% while the remission rates were 67% and 33% respectively for patients in whom both normal and abnormal metaphases were seen (AN patients) and for those in whom only abnormal metaphases were noted (AA patients). In all FAB subgroups, complete remission was related to chromosomal abnormalities, except for M4 patients who evidenced a large number of complete remissions, although presenting more chromosomal abnormalities. The longer survival in this subgroup may be related to rearrangements of chromosome 16, which is associated with a better prognosis.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000782:Aneuploidy; D001853:Bone Marrow / Q000473:pathology; D002478:Cells, Cultured; D002648:Child; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D004171:Diploidy; D005260:Female; D006801:Humans; D007621:Karyotyping; D007938:Leukemia / Q000235:genetics*; D008297:Male; D008677:Metaphase; D008875:Middle Aged